NDC Code(s) : 0019-9883-03, 0019-9884-04, 0019-9885-05, 0019-9886-06, 0019-9887-07, 0019-9888-08, 0019-9889-09, 0019-9890-10, 0019-9891-11, 0019-9892-12, 0019-9893-13, 0019-9894-14, 0019-9895-15
Packager : Mallinckrodt Inc.

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

Ultra-TechneKow Technetium Tc-99m INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0019-9883
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TECHNETIUM TC-99M SODIUM PERTECHNETATE(UNII: A0730CX801)
(TECHNETIUM TC-99M PERTECHNETATE - UNII:PPP8783IQ1)
TECHNETIUM TC-99M PERTECHNETATE1 Ci
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0019-9883-031 in 1 CARTON Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017243 07/16/1996
Ultra-TechneKow Technetium Tc-99m INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0019-9884
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TECHNETIUM TC-99M SODIUM PERTECHNETATE(UNII: A0730CX801)
(TECHNETIUM TC-99M PERTECHNETATE - UNII:PPP8783IQ1)
TECHNETIUM TC-99M PERTECHNETATE1.5 Ci
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0019-9884-041 in 1 CARTON Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017243 07/16/1996
Ultra-TechneKow Technetium Tc-99m INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0019-9885
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TECHNETIUM TC-99M SODIUM PERTECHNETATE(UNII: A0730CX801)
(TECHNETIUM TC-99M PERTECHNETATE - UNII:PPP8783IQ1)
TECHNETIUM TC-99M PERTECHNETATE2 Ci
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0019-9885-051 in 1 CARTON Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017243 07/16/1996
Ultra-TechneKow Technetium Tc-99m INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0019-9886
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TECHNETIUM TC-99M SODIUM PERTECHNETATE(UNII: A0730CX801)
(TECHNETIUM TC-99M PERTECHNETATE - UNII:PPP8783IQ1)
TECHNETIUM TC-99M PERTECHNETATE2.5 Ci
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0019-9886-061 in 1 CARTON Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017243 07/16/1996
Ultra-TechneKow Technetium Tc-99m INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0019-9887
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TECHNETIUM TC-99M SODIUM PERTECHNETATE(UNII: A0730CX801)
(TECHNETIUM TC-99M PERTECHNETATE - UNII:PPP8783IQ1)
TECHNETIUM TC-99M PERTECHNETATE3 Ci
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0019-9887-071 in 1 CARTON Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017243 07/16/1996
Ultra-TechneKow Technetium Tc-99m INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0019-9888
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TECHNETIUM TC-99M SODIUM PERTECHNETATE(UNII: A0730CX801)
(TECHNETIUM TC-99M PERTECHNETATE - UNII:PPP8783IQ1)
TECHNETIUM TC-99M PERTECHNETATE3.5 Ci
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0019-9888-081 in 1 CARTON Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017243 07/01/2005
Ultra-TechneKow Technetium Tc-99m INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0019-9889
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TECHNETIUM TC-99M SODIUM PERTECHNETATE(UNII: A0730CX801)
(TECHNETIUM TC-99M PERTECHNETATE - UNII:PPP8783IQ1)
TECHNETIUM TC-99M PERTECHNETATE5 Ci
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0019-9889-091 in 1 CARTON Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017243 07/01/2005
Ultra-TechneKow Technetium Tc-99m INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0019-9890
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TECHNETIUM TC-99M SODIUM PERTECHNETATE(UNII: A0730CX801)
(TECHNETIUM TC-99M PERTECHNETATE - UNII:PPP8783IQ1)
TECHNETIUM TC-99M PERTECHNETATE6 Ci
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0019-9890-101 in 1 CARTON Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017243 07/01/2005
Ultra-TechneKow Technetium Tc-99m INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0019-9891
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TECHNETIUM TC-99M SODIUM PERTECHNETATE(UNII: A0730CX801)
(TECHNETIUM TC-99M PERTECHNETATE - UNII:PPP8783IQ1)
TECHNETIUM TC-99M PERTECHNETATE7.5 Ci
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0019-9891-111 in 1 CARTON Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017243 07/01/2005
Ultra-TechneKow Technetium Tc-99m INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0019-9892
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TECHNETIUM TC-99M SODIUM PERTECHNETATE(UNII: A0730CX801)
(TECHNETIUM TC-99M PERTECHNETATE - UNII:PPP8783IQ1)
TECHNETIUM TC-99M PERTECHNETATE11 Ci
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0019-9892-121 in 1 CARTON Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017243 07/01/2005
Ultra-TechneKow Technetium Tc-99m INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0019-9893
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TECHNETIUM TC-99M SODIUM PERTECHNETATE(UNII: A0730CX801)
(TECHNETIUM TC-99M PERTECHNETATE - UNII:PPP8783IQ1)
TECHNETIUM TC-99M PERTECHNETATE14 Ci
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0019-9893-131 in 1 CARTON Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017243 07/01/2005
Ultra-TechneKow Technetium Tc-99m INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0019-9894
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TECHNETIUM TC-99M SODIUM PERTECHNETATE(UNII: A0730CX801)
(TECHNETIUM TC-99M PERTECHNETATE - UNII:PPP8783IQ1)
TECHNETIUM TC-99M PERTECHNETATE16 Ci
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0019-9894-141 in 1 CARTON Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017243 07/01/2005
Ultra-TechneKow Technetium Tc-99m INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0019-9895
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TECHNETIUM TC-99M SODIUM PERTECHNETATE(UNII: A0730CX801)
(TECHNETIUM TC-99M PERTECHNETATE - UNII:PPP8783IQ1)
TECHNETIUM TC-99M PERTECHNETATE19 Ci
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0019-9895-151 in 1 CARTON Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017243 07/01/2005

PRINCIPAL DISPLAY PANEL

Ultra-TechneKow™ DTE

A880CO
R12/2012

CAUTION
RADIOACTIVE MATERIAL

TECHNETIUM Tc 99m GENERATOR
Parent Molybdenum 99 prepared from Fission Produced Molybdenum 99
Store At Controlled Room Temperature 20-25°C (68-77°F)

 MOLYBDENUM 99
DECAY CHART
 TECHNETIUM 99m
DECAY CHART
 HALF-LIFE 66.0 HOURS  HALF-LIFE 66.0 HOURS
 DAYS  FRACTION
REMAINING
 DAYS  FRACTION
REMAINING
 0  1.000  -5  1.778
 1  0.777  -4  1.585
 2  0.604  -3  1.413
 3  0.469  -2  1.259
 4  0.365  -1  1.122
 5  0.284  0  1.000
 6  0.220  1  0.891
 7  0.171  2  0.794
 8  0.133  3  0.708
 9  0.103  4  0.631
 10  0.080  5  0.562
 11  0.063  6  0.501
 12  0.049  7  0.447
 13  0.038  8  0.398
 14  0.029  9  0.355
 15  0.023  10  0.316
 20  0.006  11  0.282
 25  0.002  12  0.251
 30  0.0005  14  0.199
     16  0.158
     18  0.126
     24  0.063

WARNING: Radiopharmaceuticals, produced by nuclear reactor or particle accelerator, should be used only by physicians who are qualified by specific training in the use and safe handling of radioisotopes and whose experience and training have been approved by an individual agency or institution already licensed in the use of radioisotopes.

For the production of sterile, non-pyrogenic Sodium Pertechnetate Tc 99m injection.

Rx Only.

This generator, its manufacture and use are covered by one or more of the following U.S. patents: 3,382,152; 3,446,965; 3,535,085; 3,655,981.

FOR ADDITIONAL INFORMATION SEE PACKAGE INSERT

Manufactured by:
Mallinckrodt Inc.
St. Louis, MO 63134 USA

Mallinckrodt

Distributed in Canada by:
Mallinckrodt Canada ULC
Kirkland, QC, Canada H9J 3Z4
Estb. Lic,: 102017-B

Principal Display Panel

PRINCIPAL DISPLAY PANEL

Ultra-TechneKow™ DTE

A880CO
R12/2012

CAUTION
RADIOACTIVE MATERIAL

TECHNETIUM Tc 99m GENERATOR
Parent Molybdenum 99 prepared from Fission Produced Molybdenum 99
Store At Controlled Room Temperature 20-25°C (68-77°F)

 MOLYBDENUM 99
DECAY CHART
 TECHNETIUM 99m
DECAY CHART
 HALF-LIFE 66.0 HOURS  HALF-LIFE 66.0 HOURS
 DAYS  FRACTION
REMAINING
 DAYS  FRACTION
REMAINING
 0  1.000  -5  1.778
 1  0.777  -4  1.585
 2  0.604  -3  1.413
 3  0.469  -2  1.259
 4  0.365  -1  1.122
 5  0.284  0  1.000
 6  0.220  1  0.891
 7  0.171  2  0.794
 8  0.133  3  0.708
 9  0.103  4  0.631
 10  0.080  5  0.562
 11  0.063  6  0.501
 12  0.049  7  0.447
 13  0.038  8  0.398
 14  0.029  9  0.355
 15  0.023  10  0.316
 20  0.006  11  0.282
 25  0.002  12  0.251
 30  0.0005  14  0.199
     16  0.158
     18  0.126
     24  0.063

WARNING: Radiopharmaceuticals, produced by nuclear reactor or particle accelerator, should be used only by physicians who are qualified by specific training in the use and safe handling of radioisotopes and whose experience and training have been approved by an individual agency or institution already licensed in the use of radioisotopes.

For the production of sterile, non-pyrogenic Sodium Pertechnetate Tc 99m injection.

Rx Only.

This generator, its manufacture and use are covered by one or more of the following U.S. patents: 3,382,152; 3,446,965; 3,535,085; 3,655,981.

FOR ADDITIONAL INFORMATION SEE PACKAGE INSERT

Manufactured by:
Mallinckrodt Inc.
St. Louis, MO 63134 USA

Mallinckrodt

Distributed in Canada by:
Mallinckrodt Canada ULC
Kirkland, QC, Canada H9J 3Z4
Estb. Lic,: 102017-B

Principal Display Panel

PRINCIPAL DISPLAY PANEL

Ultra-TechneKow™ DTE

A880CO
R12/2012

CAUTION
RADIOACTIVE MATERIAL

TECHNETIUM Tc 99m GENERATOR
Parent Molybdenum 99 prepared from Fission Produced Molybdenum 99
Store At Controlled Room Temperature 20-25°C (68-77°F)

 MOLYBDENUM 99
DECAY CHART
 TECHNETIUM 99m
DECAY CHART
 HALF-LIFE 66.0 HOURS  HALF-LIFE 66.0 HOURS
 DAYS  FRACTION
REMAINING
 DAYS  FRACTION
REMAINING
 0  1.000  -5  1.778
 1  0.777  -4  1.585
 2  0.604  -3  1.413
 3  0.469  -2  1.259
 4  0.365  -1  1.122
 5  0.284  0  1.000
 6  0.220  1  0.891
 7  0.171  2  0.794
 8  0.133  3  0.708
 9  0.103  4  0.631
 10  0.080  5  0.562
 11  0.063  6  0.501
 12  0.049  7  0.447
 13  0.038  8  0.398
 14  0.029  9  0.355
 15  0.023  10  0.316
 20  0.006  11  0.282
 25  0.002  12  0.251
 30  0.0005  14  0.199
     16  0.158
     18  0.126
     24  0.063

WARNING: Radiopharmaceuticals, produced by nuclear reactor or particle accelerator, should be used only by physicians who are qualified by specific training in the use and safe handling of radioisotopes and whose experience and training have been approved by an individual agency or institution already licensed in the use of radioisotopes.

For the production of sterile, non-pyrogenic Sodium Pertechnetate Tc 99m injection.

Rx Only.

This generator, its manufacture and use are covered by one or more of the following U.S. patents: 3,382,152; 3,446,965; 3,535,085; 3,655,981.

FOR ADDITIONAL INFORMATION SEE PACKAGE INSERT

Manufactured by:
Mallinckrodt Inc.
St. Louis, MO 63134 USA

Mallinckrodt

Distributed in Canada by:
Mallinckrodt Canada ULC
Kirkland, QC, Canada H9J 3Z4
Estb. Lic,: 102017-B

Principal Display Panel

PRINCIPAL DISPLAY PANEL

Ultra-TechneKow™ DTE

A880CO
R12/2012

CAUTION
RADIOACTIVE MATERIAL

TECHNETIUM Tc 99m GENERATOR
Parent Molybdenum 99 prepared from Fission Produced Molybdenum 99
Store At Controlled Room Temperature 20-25°C (68-77°F)

 MOLYBDENUM 99
DECAY CHART
 TECHNETIUM 99m
DECAY CHART
 HALF-LIFE 66.0 HOURS  HALF-LIFE 66.0 HOURS
 DAYS  FRACTION
REMAINING
 DAYS  FRACTION
REMAINING
 0  1.000  -5  1.778
 1  0.777  -4  1.585
 2  0.604  -3  1.413
 3  0.469  -2  1.259
 4  0.365  -1  1.122
 5  0.284  0  1.000
 6  0.220  1  0.891
 7  0.171  2  0.794
 8  0.133  3  0.708
 9  0.103  4  0.631
 10  0.080  5  0.562
 11  0.063  6  0.501
 12  0.049  7  0.447
 13  0.038  8  0.398
 14  0.029  9  0.355
 15  0.023  10  0.316
 20  0.006  11  0.282
 25  0.002  12  0.251
 30  0.0005  14  0.199
     16  0.158
     18  0.126
     24  0.063

WARNING: Radiopharmaceuticals, produced by nuclear reactor or particle accelerator, should be used only by physicians who are qualified by specific training in the use and safe handling of radioisotopes and whose experience and training have been approved by an individual agency or institution already licensed in the use of radioisotopes.

For the production of sterile, non-pyrogenic Sodium Pertechnetate Tc 99m injection.

Rx Only.

This generator, its manufacture and use are covered by one or more of the following U.S. patents: 3,382,152; 3,446,965; 3,535,085; 3,655,981.

FOR ADDITIONAL INFORMATION SEE PACKAGE INSERT

Manufactured by:
Mallinckrodt Inc.
St. Louis, MO 63134 USA

Mallinckrodt

Distributed in Canada by:
Mallinckrodt Canada ULC
Kirkland, QC, Canada H9J 3Z4
Estb. Lic,: 102017-B

Principal Display Panel

PRINCIPAL DISPLAY PANEL

Ultra-TechneKow™ DTE

A880CO
R12/2012

CAUTION
RADIOACTIVE MATERIAL

TECHNETIUM Tc 99m GENERATOR
Parent Molybdenum 99 prepared from Fission Produced Molybdenum 99
Store At Controlled Room Temperature 20-25°C (68-77°F)

 MOLYBDENUM 99
DECAY CHART
 TECHNETIUM 99m
DECAY CHART
 HALF-LIFE 66.0 HOURS  HALF-LIFE 66.0 HOURS
 DAYS  FRACTION
REMAINING
 DAYS  FRACTION
REMAINING
 0  1.000  -5  1.778
 1  0.777  -4  1.585
 2  0.604  -3  1.413
 3  0.469  -2  1.259
 4  0.365  -1  1.122
 5  0.284  0  1.000
 6  0.220  1  0.891
 7  0.171  2  0.794
 8  0.133  3  0.708
 9  0.103  4  0.631
 10  0.080  5  0.562
 11  0.063  6  0.501
 12  0.049  7  0.447
 13  0.038  8  0.398
 14  0.029  9  0.355
 15  0.023  10  0.316
 20  0.006  11  0.282
 25  0.002  12  0.251
 30  0.0005  14  0.199
     16  0.158
     18  0.126
     24  0.063

WARNING: Radiopharmaceuticals, produced by nuclear reactor or particle accelerator, should be used only by physicians who are qualified by specific training in the use and safe handling of radioisotopes and whose experience and training have been approved by an individual agency or institution already licensed in the use of radioisotopes.

For the production of sterile, non-pyrogenic Sodium Pertechnetate Tc 99m injection.

Rx Only.

This generator, its manufacture and use are covered by one or more of the following U.S. patents: 3,382,152; 3,446,965; 3,535,085; 3,655,981.

FOR ADDITIONAL INFORMATION SEE PACKAGE INSERT

Manufactured by:
Mallinckrodt Inc.
St. Louis, MO 63134 USA

Mallinckrodt

Distributed in Canada by:
Mallinckrodt Canada ULC
Kirkland, QC, Canada H9J 3Z4
Estb. Lic,: 102017-B

Principal Display Panel

PRINCIPAL DISPLAY PANEL

Ultra-TechneKow™ DTE

A880CO
R12/2012

CAUTION
RADIOACTIVE MATERIAL

TECHNETIUM Tc 99m GENERATOR
Parent Molybdenum 99 prepared from Fission Produced Molybdenum 99
Store At Controlled Room Temperature 20-25°C (68-77°F)

 MOLYBDENUM 99
DECAY CHART
 TECHNETIUM 99m
DECAY CHART
 HALF-LIFE 66.0 HOURS  HALF-LIFE 66.0 HOURS
 DAYS  FRACTION
REMAINING
 DAYS  FRACTION
REMAINING
 0  1.000  -5  1.778
 1  0.777  -4  1.585
 2  0.604  -3  1.413
 3  0.469  -2  1.259
 4  0.365  -1  1.122
 5  0.284  0  1.000
 6  0.220  1  0.891
 7  0.171  2  0.794
 8  0.133  3  0.708
 9  0.103  4  0.631
 10  0.080  5  0.562
 11  0.063  6  0.501
 12  0.049  7  0.447
 13  0.038  8  0.398
 14  0.029  9  0.355
 15  0.023  10  0.316
 20  0.006  11  0.282
 25  0.002  12  0.251
 30  0.0005  14  0.199
     16  0.158
     18  0.126
     24  0.063

WARNING: Radiopharmaceuticals, produced by nuclear reactor or particle accelerator, should be used only by physicians who are qualified by specific training in the use and safe handling of radioisotopes and whose experience and training have been approved by an individual agency or institution already licensed in the use of radioisotopes.

For the production of sterile, non-pyrogenic Sodium Pertechnetate Tc 99m injection.

Rx Only.

This generator, its manufacture and use are covered by one or more of the following U.S. patents: 3,382,152; 3,446,965; 3,535,085; 3,655,981.

FOR ADDITIONAL INFORMATION SEE PACKAGE INSERT

Manufactured by:
Mallinckrodt Inc.
St. Louis, MO 63134 USA

Mallinckrodt

Distributed in Canada by:
Mallinckrodt Canada ULC
Kirkland, QC, Canada H9J 3Z4
Estb. Lic,: 102017-B

Principal Display Panel

PRINCIPAL DISPLAY PANEL

Ultra-TechneKow™ DTE

A880CO
R12/2012

CAUTION
RADIOACTIVE MATERIAL

TECHNETIUM Tc 99m GENERATOR
Parent Molybdenum 99 prepared from Fission Produced Molybdenum 99
Store At Controlled Room Temperature 20-25°C (68-77°F)

 MOLYBDENUM 99
DECAY CHART
 TECHNETIUM 99m
DECAY CHART
 HALF-LIFE 66.0 HOURS  HALF-LIFE 66.0 HOURS
 DAYS  FRACTION
REMAINING
 DAYS  FRACTION
REMAINING
 0  1.000  -5  1.778
 1  0.777  -4  1.585
 2  0.604  -3  1.413
 3  0.469  -2  1.259
 4  0.365  -1  1.122
 5  0.284  0  1.000
 6  0.220  1  0.891
 7  0.171  2  0.794
 8  0.133  3  0.708
 9  0.103  4  0.631
 10  0.080  5  0.562
 11  0.063  6  0.501
 12  0.049  7  0.447
 13  0.038  8  0.398
 14  0.029  9  0.355
 15  0.023  10  0.316
 20  0.006  11  0.282
 25  0.002  12  0.251
 30  0.0005  14  0.199
     16  0.158
     18  0.126
     24  0.063

WARNING: Radiopharmaceuticals, produced by nuclear reactor or particle accelerator, should be used only by physicians who are qualified by specific training in the use and safe handling of radioisotopes and whose experience and training have been approved by an individual agency or institution already licensed in the use of radioisotopes.

For the production of sterile, non-pyrogenic Sodium Pertechnetate Tc 99m injection.

Rx Only.

This generator, its manufacture and use are covered by one or more of the following U.S. patents: 3,382,152; 3,446,965; 3,535,085; 3,655,981.

FOR ADDITIONAL INFORMATION SEE PACKAGE INSERT

Manufactured by:
Mallinckrodt Inc.
St. Louis, MO 63134 USA

Mallinckrodt

Distributed in Canada by:
Mallinckrodt Canada ULC
Kirkland, QC, Canada H9J 3Z4
Estb. Lic,: 102017-B

Principal Display Panel

PRINCIPAL DISPLAY PANEL

Ultra-TechneKow™ DTE

A880CO
R12/2012

CAUTION
RADIOACTIVE MATERIAL

TECHNETIUM Tc 99m GENERATOR
Parent Molybdenum 99 prepared from Fission Produced Molybdenum 99
Store At Controlled Room Temperature 20-25°C (68-77°F)

 MOLYBDENUM 99
DECAY CHART
 TECHNETIUM 99m
DECAY CHART
 HALF-LIFE 66.0 HOURS  HALF-LIFE 66.0 HOURS
 DAYS  FRACTION
REMAINING
 DAYS  FRACTION
REMAINING
 0  1.000  -5  1.778
 1  0.777  -4  1.585
 2  0.604  -3  1.413
 3  0.469  -2  1.259
 4  0.365  -1  1.122
 5  0.284  0  1.000
 6  0.220  1  0.891
 7  0.171  2  0.794
 8  0.133  3  0.708
 9  0.103  4  0.631
 10  0.080  5  0.562
 11  0.063  6  0.501
 12  0.049  7  0.447
 13  0.038  8  0.398
 14  0.029  9  0.355
 15  0.023  10  0.316
 20  0.006  11  0.282
 25  0.002  12  0.251
 30  0.0005  14  0.199
     16  0.158
     18  0.126
     24  0.063

WARNING: Radiopharmaceuticals, produced by nuclear reactor or particle accelerator, should be used only by physicians who are qualified by specific training in the use and safe handling of radioisotopes and whose experience and training have been approved by an individual agency or institution already licensed in the use of radioisotopes.

For the production of sterile, non-pyrogenic Sodium Pertechnetate Tc 99m injection.

Rx Only.

This generator, its manufacture and use are covered by one or more of the following U.S. patents: 3,382,152; 3,446,965; 3,535,085; 3,655,981.

FOR ADDITIONAL INFORMATION SEE PACKAGE INSERT

Manufactured by:
Mallinckrodt Inc.
St. Louis, MO 63134 USA

Mallinckrodt

Distributed in Canada by:
Mallinckrodt Canada ULC
Kirkland, QC, Canada H9J 3Z4
Estb. Lic,: 102017-B

Principal Display Panel

PRINCIPAL DISPLAY PANEL

Ultra-TechneKow™ DTE

A880CO
R12/2012

CAUTION
RADIOACTIVE MATERIAL

TECHNETIUM Tc 99m GENERATOR
Parent Molybdenum 99 prepared from Fission Produced Molybdenum 99
Store At Controlled Room Temperature 20-25°C (68-77°F)

 MOLYBDENUM 99
DECAY CHART
 TECHNETIUM 99m
DECAY CHART
 HALF-LIFE 66.0 HOURS  HALF-LIFE 66.0 HOURS
 DAYS  FRACTION
REMAINING
 DAYS  FRACTION
REMAINING
 0  1.000  -5  1.778
 1  0.777  -4  1.585
 2  0.604  -3  1.413
 3  0.469  -2  1.259
 4  0.365  -1  1.122
 5  0.284  0  1.000
 6  0.220  1  0.891
 7  0.171  2  0.794
 8  0.133  3  0.708
 9  0.103  4  0.631
 10  0.080  5  0.562
 11  0.063  6  0.501
 12  0.049  7  0.447
 13  0.038  8  0.398
 14  0.029  9  0.355
 15  0.023  10  0.316
 20  0.006  11  0.282
 25  0.002  12  0.251
 30  0.0005  14  0.199
     16  0.158
     18  0.126
     24  0.063

WARNING: Radiopharmaceuticals, produced by nuclear reactor or particle accelerator, should be used only by physicians who are qualified by specific training in the use and safe handling of radioisotopes and whose experience and training have been approved by an individual agency or institution already licensed in the use of radioisotopes.

For the production of sterile, non-pyrogenic Sodium Pertechnetate Tc 99m injection.

Rx Only.

This generator, its manufacture and use are covered by one or more of the following U.S. patents: 3,382,152; 3,446,965; 3,535,085; 3,655,981.

FOR ADDITIONAL INFORMATION SEE PACKAGE INSERT

Manufactured by:
Mallinckrodt Inc.
St. Louis, MO 63134 USA

Mallinckrodt

Distributed in Canada by:
Mallinckrodt Canada ULC
Kirkland, QC, Canada H9J 3Z4
Estb. Lic,: 102017-B

Principal Display Panel

PRINCIPAL DISPLAY PANEL

Ultra-TechneKow™ DTE

A880CO
R12/2012

CAUTION
RADIOACTIVE MATERIAL

TECHNETIUM Tc 99m GENERATOR
Parent Molybdenum 99 prepared from Fission Produced Molybdenum 99
Store At Controlled Room Temperature 20-25°C (68-77°F)

 MOLYBDENUM 99
DECAY CHART
 TECHNETIUM 99m
DECAY CHART
 HALF-LIFE 66.0 HOURS  HALF-LIFE 66.0 HOURS
 DAYS  FRACTION
REMAINING
 DAYS  FRACTION
REMAINING
 0  1.000  -5  1.778
 1  0.777  -4  1.585
 2  0.604  -3  1.413
 3  0.469  -2  1.259
 4  0.365  -1  1.122
 5  0.284  0  1.000
 6  0.220  1  0.891
 7  0.171  2  0.794
 8  0.133  3  0.708
 9  0.103  4  0.631
 10  0.080  5  0.562
 11  0.063  6  0.501
 12  0.049  7  0.447
 13  0.038  8  0.398
 14  0.029  9  0.355
 15  0.023  10  0.316
 20  0.006  11  0.282
 25  0.002  12  0.251
 30  0.0005  14  0.199
     16  0.158
     18  0.126
     24  0.063

WARNING: Radiopharmaceuticals, produced by nuclear reactor or particle accelerator, should be used only by physicians who are qualified by specific training in the use and safe handling of radioisotopes and whose experience and training have been approved by an individual agency or institution already licensed in the use of radioisotopes.

For the production of sterile, non-pyrogenic Sodium Pertechnetate Tc 99m injection.

Rx Only.

This generator, its manufacture and use are covered by one or more of the following U.S. patents: 3,382,152; 3,446,965; 3,535,085; 3,655,981.

FOR ADDITIONAL INFORMATION SEE PACKAGE INSERT

Manufactured by:
Mallinckrodt Inc.
St. Louis, MO 63134 USA

Mallinckrodt

Distributed in Canada by:
Mallinckrodt Canada ULC
Kirkland, QC, Canada H9J 3Z4
Estb. Lic,: 102017-B

Principal Display Panel

PRINCIPAL DISPLAY PANEL

Ultra-TechneKow™ DTE

A880CO
R12/2012

CAUTION
RADIOACTIVE MATERIAL

TECHNETIUM Tc 99m GENERATOR
Parent Molybdenum 99 prepared from Fission Produced Molybdenum 99
Store At Controlled Room Temperature 20-25°C (68-77°F)

 MOLYBDENUM 99
DECAY CHART
 TECHNETIUM 99m
DECAY CHART
 HALF-LIFE 66.0 HOURS  HALF-LIFE 66.0 HOURS
 DAYS  FRACTION
REMAINING
 DAYS  FRACTION
REMAINING
 0  1.000  -5  1.778
 1  0.777  -4  1.585
 2  0.604  -3  1.413
 3  0.469  -2  1.259
 4  0.365  -1  1.122
 5  0.284  0  1.000
 6  0.220  1  0.891
 7  0.171  2  0.794
 8  0.133  3  0.708
 9  0.103  4  0.631
 10  0.080  5  0.562
 11  0.063  6  0.501
 12  0.049  7  0.447
 13  0.038  8  0.398
 14  0.029  9  0.355
 15  0.023  10  0.316
 20  0.006  11  0.282
 25  0.002  12  0.251
 30  0.0005  14  0.199
     16  0.158
     18  0.126
     24  0.063

WARNING: Radiopharmaceuticals, produced by nuclear reactor or particle accelerator, should be used only by physicians who are qualified by specific training in the use and safe handling of radioisotopes and whose experience and training have been approved by an individual agency or institution already licensed in the use of radioisotopes.

For the production of sterile, non-pyrogenic Sodium Pertechnetate Tc 99m injection.

Rx Only.

This generator, its manufacture and use are covered by one or more of the following U.S. patents: 3,382,152; 3,446,965; 3,535,085; 3,655,981.

FOR ADDITIONAL INFORMATION SEE PACKAGE INSERT

Manufactured by:
Mallinckrodt Inc.
St. Louis, MO 63134 USA

Mallinckrodt

Distributed in Canada by:
Mallinckrodt Canada ULC
Kirkland, QC, Canada H9J 3Z4
Estb. Lic,: 102017-B

Principal Display Panel

PRINCIPAL DISPLAY PANEL

Ultra-TechneKow™ DTE

A880CO
R12/2012

CAUTION
RADIOACTIVE MATERIAL

TECHNETIUM Tc 99m GENERATOR
Parent Molybdenum 99 prepared from Fission Produced Molybdenum 99
Store At Controlled Room Temperature 20-25°C (68-77°F)

 MOLYBDENUM 99
DECAY CHART
 TECHNETIUM 99m
DECAY CHART
 HALF-LIFE 66.0 HOURS  HALF-LIFE 66.0 HOURS
 DAYS  FRACTION
REMAINING
 DAYS  FRACTION
REMAINING
 0  1.000  -5  1.778
 1  0.777  -4  1.585
 2  0.604  -3  1.413
 3  0.469  -2  1.259
 4  0.365  -1  1.122
 5  0.284  0  1.000
 6  0.220  1  0.891
 7  0.171  2  0.794
 8  0.133  3  0.708
 9  0.103  4  0.631
 10  0.080  5  0.562
 11  0.063  6  0.501
 12  0.049  7  0.447
 13  0.038  8  0.398
 14  0.029  9  0.355
 15  0.023  10  0.316
 20  0.006  11  0.282
 25  0.002  12  0.251
 30  0.0005  14  0.199
     16  0.158
     18  0.126
     24  0.063

WARNING: Radiopharmaceuticals, produced by nuclear reactor or particle accelerator, should be used only by physicians who are qualified by specific training in the use and safe handling of radioisotopes and whose experience and training have been approved by an individual agency or institution already licensed in the use of radioisotopes.

For the production of sterile, non-pyrogenic Sodium Pertechnetate Tc 99m injection.

Rx Only.

This generator, its manufacture and use are covered by one or more of the following U.S. patents: 3,382,152; 3,446,965; 3,535,085; 3,655,981.

FOR ADDITIONAL INFORMATION SEE PACKAGE INSERT

Manufactured by:
Mallinckrodt Inc.
St. Louis, MO 63134 USA

Mallinckrodt

Distributed in Canada by:
Mallinckrodt Canada ULC
Kirkland, QC, Canada H9J 3Z4
Estb. Lic,: 102017-B

Principal Display Panel

PRINCIPAL DISPLAY PANEL

Ultra-TechneKow™ DTE

A880CO
R12/2012

CAUTION
RADIOACTIVE MATERIAL

TECHNETIUM Tc 99m GENERATOR
Parent Molybdenum 99 prepared from Fission Produced Molybdenum 99
Store At Controlled Room Temperature 20-25°C (68-77°F)

 MOLYBDENUM 99
DECAY CHART
 TECHNETIUM 99m
DECAY CHART
 HALF-LIFE 66.0 HOURS  HALF-LIFE 66.0 HOURS
 DAYS  FRACTION
REMAINING
 DAYS  FRACTION
REMAINING
 0  1.000  -5  1.778
 1  0.777  -4  1.585
 2  0.604  -3  1.413
 3  0.469  -2  1.259
 4  0.365  -1  1.122
 5  0.284  0  1.000
 6  0.220  1  0.891
 7  0.171  2  0.794
 8  0.133  3  0.708
 9  0.103  4  0.631
 10  0.080  5  0.562
 11  0.063  6  0.501
 12  0.049  7  0.447
 13  0.038  8  0.398
 14  0.029  9  0.355
 15  0.023  10  0.316
 20  0.006  11  0.282
 25  0.002  12  0.251
 30  0.0005  14  0.199
     16  0.158
     18  0.126
     24  0.063

WARNING: Radiopharmaceuticals, produced by nuclear reactor or particle accelerator, should be used only by physicians who are qualified by specific training in the use and safe handling of radioisotopes and whose experience and training have been approved by an individual agency or institution already licensed in the use of radioisotopes.

For the production of sterile, non-pyrogenic Sodium Pertechnetate Tc 99m injection.

Rx Only.

This generator, its manufacture and use are covered by one or more of the following U.S. patents: 3,382,152; 3,446,965; 3,535,085; 3,655,981.

FOR ADDITIONAL INFORMATION SEE PACKAGE INSERT

Manufactured by:
Mallinckrodt Inc.
St. Louis, MO 63134 USA

Mallinckrodt

Distributed in Canada by:
Mallinckrodt Canada ULC
Kirkland, QC, Canada H9J 3Z4
Estb. Lic,: 102017-B

Principal Display Panel